← Back to Search

Other

Ketogenic Diet for Mantle Cell Lymphoma

N/A
Waitlist Available
Led By Peter Martin, M.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial looks at how well people with a low amount of cancer cells in their body follow a ketogenic diet.

Eligible Conditions
  • Mantle Cell Lymphoma
  • Ketogenic Diet

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of subjects who adhere to ketogenic diet
Secondary outcome measures
Change in body composition as measured by difference in ideal body weight and actual body weight at the end of study compared to baseline
Effect of ketogenic diet on gut microbiome
Number of subjects who achieve a partial or complete response
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All SubjectsExperimental Treatment1 Intervention
Low tumor burden, treatment-naïve MCL

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,059 Previous Clinical Trials
1,316,143 Total Patients Enrolled
Peter Martin, M.D.Principal InvestigatorWeill Medical College of Cornell University
~0 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top